Salmonella Abortusovis (SAO), a sheep-adapted serotype, is the main cause of [...]
Diatheva is featured in the Italy Life Sciences 2021 Report published by Global Business Reports (GBR).
Can you introduce Diatheva and its position within SOL Group? [...]
In 16.6% of spontaneous abortion cases L. monocytogenes is the [...]
DIATHEVA presented a new product in pipeline "scFv 2G8" [...]
Diatheva’s pipeline antibody-based therapies is designated to address significant unmet [...]
DIATHEVA , partner in the co-development of a recombinant antibody for the treatment of Ewing Sarcoma
A recent paper published in the prestigious scientific journal Clinical [...]